This inventor holds 1 USPTO granted patent. Top assignee: Pliva, Farmaceutska, Kemijska, Prehrambena I Kozmeticka Industrija,. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: Miljenko Dumi C: Innovator in Hypoglycemic Research
Introduction
Miljenko Dumi C is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with hypoglycemic activity. His work is characterized by a focus on innovative chemical solutions that address important health issues.
Latest Patents
Dumi C holds a patent for "Hydroxylamines with hypoglycemic activity." This patent describes the preparation of novel 1-(2-,3- or 4-hydroxylaminobenzensulfonyl-1a,2,6,6 a-tetrahydro-1H,4H-[1,3]-dioxepino[5,6-b]azirines with hypoglycemic activity through the selective reduction of appropriate 1-(2-,3- or 4-nitrobenzenesulfonyl) derivatives. This innovative approach has the potential to contribute to diabetes management.
Career Highlights
Miljenko Dumi C is associated with Pliva, a prominent pharmaceutical, chemical, food, and cosmetic industry company. His work at Pliva has allowed him to engage in cutting-edge research and development, furthering advancements in medical science.
Collaborations
Dumi C has collaborated with several talented individuals, including Mirela E Skinja and Blanka Jamnicky. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Miljenko Dumi C is a distinguished inventor whose work in hypoglycemic research exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions continue to pave the way for advancements in health solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile